LDH and renal function are prognostic factors for long-term outcomes of multiple myeloma patients undergoing allogeneic hematopoietic stem cell
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LDH and renal function are prognostic factors for long-term outcomes of multiple myeloma patients undergoing allogeneic hematopoietic stem cell
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-17
DOI
10.1038/s41409-020-0829-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens
- (2019) Hossein Maymani et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma
- (2019) Lucia López-Corral et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Clonal evolution in myeloma: a narrow road to remission
- (2019) Cornelius C. Miething HAEMATOLOGICA
- Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
- (2019) Philippe Moreau et al. LANCET
- Baseline Renal Function and Albumin are Powerful Predictors for Allogeneic Transplantation-Related Mortality
- (2018) Roni Shouval et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement
- (2018) Wilson I. Gonsalves et al. BONE MARROW TRANSPLANTATION
- Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life
- (2018) Christine Greil et al. HAEMATOLOGICA
- Long term follow-up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma
- (2018) Enrico Maffini et al. HAEMATOLOGICA
- Progress and Paradigms in Multiple Myeloma
- (2016) Kenneth C. Anderson CLINICAL CANCER RESEARCH
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
- (2016) Shaji Kumar et al. LANCET ONCOLOGY
- Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party
- (2016) M Sobh et al. LEUKEMIA
- Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
- (2015) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
- (2014) B. Gyurkocza et al. BLOOD
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study
- (2012) H. M. Lokhorst et al. BLOOD
- Tandem Autologous/Reduced-Intensity Conditioning Allogeneic Stem-Cell Transplantation Versus Autologous Transplantation in Myeloma: Long-Term Follow-Up
- (2011) Bo Björkstrand et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Follow-Up of an Intensified Myeloablative Conditioning Regimen with In Vivo T Cell Depletion Followed by Allografting in Patients with Advanced Multiple Myeloma
- (2010) Nicolaus Kröger et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma
- (2010) Avichai Shimoni et al. CANCER
- Defining the Intensity of Conditioning Regimens: Working Definitions
- (2009) Andrea Bacigalupo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Quality of life after allogeneic hematopoietic cell transplantation
- (2009) J. Pidala et al. BLOOD
- Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation
- (2009) Nicolaus Kröger et al. BRITISH JOURNAL OF HAEMATOLOGY
- A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma
- (2008) L. Rosinol et al. BLOOD
- Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma
- (2008) G Schilling et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started